Printer Friendly
The Free Library
14,670,922 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BIO Announces Initial Companies Selected to Present at the Seventh Annual Bio(R) Investor Forum.


Conference will be held October 29-31 at the Palace Hotel San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden , Calif.

WASHINGTON -- The Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
  • BIO Website
 (BIO bi·o  
n. pl. bi·os Informal
1. A biography.

2. A biographical sketch or outline.
) today announced the first 76 companies selected through a competitive screening process to present at the Seventh Annual BIO Investor Forum. Presenting companies will be asked to focus on near-term clinical catalysts and accomplishments across therapeutic fields and areas of unmet un·met  
adj.
Not satisfied or fulfilled: unmet demands. 
 medical need.

A total of 190 presenting companies will be selected and posted on the conference website on a rolling basis. To view the latest list, please visit http://investorforum.bio.org.

Select late-stage private and emerging public biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
 companies were nominated nom·i·nate  
tr.v. nom·i·nat·ed, nom·i·nat·ing, nom·i·nates
1. To propose by name as a candidate, especially for election.

2. To designate or appoint to an office, responsibility, or honor.
 by an Advisory Committee, comprised of members from top-tier firms from the buy-side, sell-side, venture capital and private equity communities:

* Gaurav Aggarwal, M.D., Panorama Capital

* Ashley Dombkowski, Ph.D., MPM MPM Multi-Processing Module (Apache)
MPM Manufacturing Process Management
MPM Milwaukee Public Museum
MPM MMW (Millimeter Wave) Power Module
MPM Master of Project Management (degree) 
 Capital

* Rishi rishi (rēˑ·shē),
n in Sanskrit, one who possesses knowledge.
 Gupta, J.D., OrbiMed Advisors, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 

* William Ho, Banc of America Securities, LLC

* Ron Laufer, M.D., Visium Asset Management

* George Milstein, Pacific Growth Equities, LLC

* Matthew Perry, Biotechnology Value Fund, LP

* Michael Wasserman, Ph.D., H.I.G. Ventures

"These clinical-stage companies represent the industry's most innovative therapeutic advances and potential investment opportunities," said Alan Eisenberg, executive vice president, Emerging Companies & Business Development at BIO. "Companies nominated by our Advisory Committee are also distinguished by significant near-term clinical, regulatory and corporate catalysts."

The BIO Investor Forum is a national investor conference featuring leading private and emerging public companies. The meeting attracts sophisticated healthcare venture and private equity investors, buy-side investors and research analysts. In addition, the BIO Investor Forum draws business development executives from leading global pharmaceutical and mature biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
.

This year's meeting will continue to explore current and competitive therapeutic development trends and investment opportunities in life sciences through therapeutic, business and plenary plenary adj. full, complete, covering all matters, usually referring to an order, hearing or trial.


PLENARY. Full, complete.
     2.
 panels. The conference will also feature BIO's web-based partnering system to arrange one-on-one meetings between registered companies, investors, and industry business development, licensing and therapeutic franchise heads.

To learn more about the BIO Investor Forum, including registration and program information, please visit http://investorforum.bio.org. Registration is complimentary for qualified investors and credentialed cre·den·tial  
n.
1. That which entitles one to confidence, credit, or authority.

2. credentials Evidence or testimonials concerning one's right to credit, confidence, or authority:
 members of the media.

The following companies will present at the Seventh Annual BIO Investor Forum:
Acadia Pharmaceuticals Inc. (ACAD)
Acceleron Pharma, Inc.
Acologix, Inc.
Acucela Inc.
Aegerion
Affymax Inc. (AFFY)
Allon Therapeutics Inc. (NPC)
Alnylam Pharmaceuticals (ALNY)
Amira Pharma
Anadys Pharmaceuticals Inc (ANDS)
Arana Therapeutics Limited (ATPCF)
Ardea Biosciences, Inc. (RDEA)
Athersys, Inc. (ATHX)
AVANT Immunotherapeutics, Inc. (AVAN)
Bayhill Therapeutics
Biolex Therapeutics
BioMimetic Therapeutics Inc (BMTI)
BiPar Sciences
BrainCells
CardioVascular BioTherapeutics Inc (CVBT)
Celator Pharmaceuticals, Inc.
Cell Therapeutics Inc (CTICD)
ChemoCentryx
CombinatoRx Inc (CRXX)
Curis Inc (CRIS)
CytRx Corporation (CYTR)
DiObex
Elixir Pharmaceuticals
Endocyte
Geron Corporation (GERN)
GlobeImmune
Glycomimetics, Inc.
Halozyme Therapeutics Inc (HALO)
Hemispherx Biopharma Inc (HEB)
Hollis-Eden Pharmaceuticals Inc (HEPH)
Hydra Biosciences
Icagen Inc (ICGN)
ImmunoGen, Inc. (IMGN)
ISTA Pharmaceuticals Inc (ISTA)
KAI Pharmaceuticals, Inc
Karo Bio AB (KARO.ST)
Macrogenics
Metabasis Therapeutics Inc (MBRX)
Metabolex
MethylGene Inc (MYLGF.PK)
Micromet Inc (MITI)
Molmed SpA (MTA:MLM)
Nabriva GMBH
Napo Pharmaceuticals Inc. (NAPL.L)
NeurAxon
Nile Therapeutics, Inc (NLTX)
Northwest Biotherapeutics Inc (NWBO.OB)
Oncolytics Biotech Inc (ONCY)
Oncothyreon Inc. (ONTY)
Pacific Biosciences
Peplin (PEPBF.PK)
Peregrine Pharmaceuticals Inc (PPHM)
Phenomix
Portola Pharmaceuticals
Presidio Pharmaceuticals
Proteolix, Inc.
QuatRx Pharmaceuticals
Reata Pharmaceuticals
Regulus Therapeutics
Relypsa
Sunesis Pharmaceuticals Inc.(SNSS)
Supernus Pharmaceuticals
Symphogen
Synageva BioPharma Corp
Syndax Pharmaceuticals
Targeted Genetics Corp (TGEN)
Tobira Therapeutics
Tranzyme Pharma
Wilex AG (WL6.DE)
XDx
Zelos Therapeutics


About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology Environmental biotechnology is when biotechnology is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation.  products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
Upcoming BIO Events

Intellectual Property Council Committee Fall Conference and Meeting
October 20-22, 2008
Orlando, Fla.

BIO HR Conference 2008
October 26-28, 2008
San Diego, Calif.

BIO-LES Advanced Business Development Course
October 27-29, 2008
San Francisco, Calif.

Seventh Annual BIO Investor Forum
October 29-31, 2008
San Francisco, Calif.

Advanced Business Development Course
November 14-16, 2008
Mannheim/Heidelberg, Germany

BIO-Europe 2008
November 17-19, 2008
Mannheim/Heidelberg, Germany

2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 16, 2008
Words:717
Previous Article:Acxiom(R) Listed on 2008 InformationWeek 500.
Next Article:Avalara Announces Strategic Partnership with Intacct.
Topics:



Related Articles
SEBIO Announces William Haseltine, Ph.D., and Arthur Klausner Will Be Luncheon Seakers at Its Annual Biotechnology Investor Forum; Founder of Human...
Tenth Annual BIO CEO & Investor Conference Registration Now Available Online.(Conference news)
BIO Investor Forum brings 200 firms, 225 VCs together; gathering focus for financing trends.(Biotechnology Industry Organization)(Conference notes)
Tenth Annual BIO CEO & Investor Conference Brings Together Industry Leaders and Investors.(Conference notes)
BIO Announces Business Forum Program for the 2008 BIO International Convention.
HemoBioTech Chairman & CEO Arthur Bollon, Ph.D., to Present at the Bio International Convention in San Diego, CA.
BIO and ABLE-India Announce First Biotechnology Partnering Event in India.
Registration Now Open for the Seventh Annual BIO Investor Forum.
BIO Announces Must-See Therapeutic Workshop Topics for Seventh Annual BIO Investor Forum.
BIO Investor Advisory: BIO Announces Must-See Therapeutic Workshop Topics for Seventh Annual BIO Investor Forum.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles